APA (7th ed.) Citation

V, R., M, L., AM, R., R, D., S, B., F, C., . . . A, R. (2026). Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMT. Bone marrow transplantation, 61(1), 75. https://doi.org/10.1038/s41409-025-02735-7

Chicago Style (17th ed.) Citation

V, Rocha, et al. "Use of Bone Marrow Cells Is Associated with Improved Outcomes When Compared to Peripheral Blood Stem Cell After Haplo-identical Transplants with Post Transplant Cyclophosphamide, a Study from of the CTIWP-EBMT." Bone Marrow Transplantation 61, no. 1 (2026): 75. https://doi.org/10.1038/s41409-025-02735-7.

MLA (9th ed.) Citation

V, Rocha, et al. "Use of Bone Marrow Cells Is Associated with Improved Outcomes When Compared to Peripheral Blood Stem Cell After Haplo-identical Transplants with Post Transplant Cyclophosphamide, a Study from of the CTIWP-EBMT." Bone Marrow Transplantation, vol. 61, no. 1, 2026, p. 75, https://doi.org/10.1038/s41409-025-02735-7.